POLXF | Polydex Pharmaceuticals Limited
Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: April 20, 2023 Before Market Opens
Company Profile The company manufactures and sells bulk quantities of dextran and derivative products to large pharmaceutical companies throughout the world. Pursuant to a definitive supply agreement with Sparhawk in the United States, the company specifically provides ferric hydroxide and hydrogenated dextran through our US subsiduary, Chemdex.
Earnings History Date EPS / Forecast Revenue / Forecast June 15, 2023 May 1, 2023 - / - - / - December 15, 2022 - / - - / - September 15, 2022 - / - - / - June 15, 2022 - / - - / - view more
Historical Data Date Price Open High Low Vol Change ER Sep 3, 2021 0.9300 0.9350 0.9350
0.9300
4.00K -0.64% Sep 2, 2021 0.9360 0.9360 0.9360
0.9360
2.36K 0% Sep 1, 2021 0.9360 0.9360 0.9360
0.9360
0.35K 0.65% Aug 19, 2021 0.9300 0.9300 0.9300
0.9300
2.00K -3.63% Aug 11, 2021 0.9650 0.9650 0.9650
0.9650
2.50K 0% Aug 9, 2021 0.9650 0.9675 0.9675
0.9650
0.50K -1.53% Aug 3, 2021 0.9800 0.9800 0.9800
0.9800
1.50K -0.56% Jul 30, 2021 0.9855 0.9855 0.9855
0.9855
1.00K -0.74% Jul 28, 2021 0.9928 0.9855 0.9928
0.9855
3.48K 0% Jul 22, 2021 0.9928 0.9928 0.9928
0.9928
0.10K 0% view more
OTCMKTS - OTC Markets Group (Over-the-Counter)
More profiles and info about the company News
Polydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09M seekingalpha.com Sep 15, 2022 9:39 pm Polydex Pharmaceuticals GAAP EPS of -$0.02, revenue of $1.15M seekingalpha.com Jun 15, 2022 9:36 pm Polydex Pharmaceuticals GAAP EPS of -$0.16, revenue of $4.23M seekingalpha.com May 3, 2022 6:09 pm Polydex Pharmaceuticals Issues First Quarter Financial Results finance.yahoo.com Jun 15, 2020 12:06 pm Polydex Pharmaceuticals Provides Year End Financial Report Closing the Year With A Strong Cash Position and Low Debt finance.yahoo.com Apr 30, 2020 6:04 pm Polydex Pharmaceuticals Limited (USA) (POLXF) - Cash Flow fool.com Mar 29, 2020 9:03 pm Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with consistent year over year sales finance.yahoo.com Dec 17, 2019 3:12 pm Polydex Pharmaceuticals reports Q3 results seekingalpha.com Dec 16, 2021 12:16 am Polydex Pharmaceuticals reports Q2 results seekingalpha.com Sep 15, 2021 8:48 pm Polydex Pharmaceuticals reports Q1 results seekingalpha.com Jun 15, 2021 9:15 pm Polydex Pharmaceuticals reports FY results seekingalpha.com Apr 30, 2021 9:46 pm Polydex Pharmaceuticals reports Q3 results seekingalpha.com Dec 15, 2020 10:30 pm Polydex Pharmaceuticals reports Q2 results seekingalpha.com Sep 15, 2020 11:47 pm Polydex Pharmaceuticals reports Q1 results seekingalpha.com Jun 15, 2020 9:39 pm Polydex Pharmaceuticals reports FY results seekingalpha.com Apr 30, 2020 9:22 pm Polydex Pharmaceuticals reports Q3 results seekingalpha.com Dec 16, 2019 7:09 pm Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with continued improving gross margins finance.yahoo.com Dec 16, 2019 7:12 am Polydex Pharmaceuticals reports Q2 results seekingalpha.com Sep 16, 2019 9:02 pm Polydex Pharmaceuticals Issues Second Quarter Financial Results finance.yahoo.com Sep 16, 2019 10:09 am This company doesn't provide a dividend.
Talk about Polydex Pharmaceuticals Limited below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet